These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 12196720

  • 1. In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.
    Takei H, Lee ES, Jordan VC.
    Breast Cancer; 2002; 9(1):39-42. PubMed ID: 12196720
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
    Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Härkönen PL.
    Mol Cell Endocrinol; 1999 Mar 25; 149(1-2):29-40. PubMed ID: 10375015
    [Abstract] [Full Text] [Related]

  • 3. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC, Schafer JM, Pearce ST, Osipo C, Chen B, Jordan VC.
    Gynecol Oncol; 2002 Jun 25; 85(3):498-506. PubMed ID: 12051881
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 5. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
    DeFriend DJ, Anderson E, Bell J, Wilks DP, West CM, Mansel RE, Howell A.
    Br J Cancer; 1994 Aug 01; 70(2):204-11. PubMed ID: 8054267
    [Abstract] [Full Text] [Related]

  • 6. Low pO2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia.
    Maity A, Sall W, Koch CJ, Oprysko PR, Evans SM.
    Breast Cancer Res Treat; 2001 May 01; 67(1):51-60. PubMed ID: 11518466
    [Abstract] [Full Text] [Related]

  • 7. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J, Kitlen JW, Briand P, Labrie F, Lykkesfeldt AE.
    J Steroid Biochem Mol Biol; 2003 Mar 01; 84(4):469-78. PubMed ID: 12732292
    [Abstract] [Full Text] [Related]

  • 8. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
    Wu J, Richer J, Horwitz KB, Hyder SM.
    Cancer Res; 2004 Mar 15; 64(6):2238-44. PubMed ID: 15026368
    [Abstract] [Full Text] [Related]

  • 9. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K, Banerjee S, Saxena N, Banerjee SK.
    Int J Oncol; 2003 Mar 15; 22(3):609-14. PubMed ID: 12579315
    [Abstract] [Full Text] [Related]

  • 10. Cyr61 promotes breast tumorigenesis and cancer progression.
    Tsai MS, Bogart DF, Castañeda JM, Li P, Lupu R.
    Oncogene; 2002 Nov 21; 21(53):8178-85. PubMed ID: 12444554
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol.
    Jiang SY, Wolf DM, Yingling JM, Chang C, Jordan VC.
    Mol Cell Endocrinol; 1992 Dec 21; 90(1):77-86. PubMed ID: 1301400
    [Abstract] [Full Text] [Related]

  • 13. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
    Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Künzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR.
    J Natl Cancer Inst; 2004 Feb 04; 96(3):210-8. PubMed ID: 14759988
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia.
    Bausero P, Ben-Mahdi M, Mazucatelli J, Bloy C, Perrot-Applanat M.
    Am J Physiol Heart Circ Physiol; 2000 Nov 04; 279(5):H2033-42. PubMed ID: 11045935
    [Abstract] [Full Text] [Related]

  • 18. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V, Gougelet A, Maillard S, Renoir JM.
    Mol Endocrinol; 2003 Oct 04; 17(10):2013-27. PubMed ID: 12855746
    [Abstract] [Full Text] [Related]

  • 19. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 04; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

  • 20. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F, Pawlowski V, Lhotellier V, Louchez MM, Peyrat JP.
    Anticancer Res; 2003 Mar 04; 23(2B):1455-60. PubMed ID: 12820409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.